登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 股东持有的基本情况 公司股东杨培勇先生系公司特定股东、第三届监事会监事，于2023年10月退休并于2024年4月25日辞去 监事职务，持有公司股份1,080,000股，占公司总股本0.6%，持有的公司股份为公司首次公开发行前取 得的股份以及公司资本公积转增股本所得，已于2024年3月18日解除限售并上市流通。 ● 减持计划的主要内容 公司近日收到股东杨培勇先生出具的《关于减持公司股份的告知函》，计划自本公告披露之日起15个交 易日后的3个月内通过集中竞价方式减持其持有的公司股份不超过250,000股，占公司总股本比例不超过 0.14%。若在减持计划实施期间公司发生送股、资本公积转增股本等股份变动事项，减持股份数将进行 相应调整。 一、减持主体的基本情况 证券代码：688616 证券简称：西力科技 公告编号：2025-038 杭州西力智能科技股份有限公司 股东减持股份计划公告 ■ 上述减持主体无一致 ...

西力科技(688616.SH)发布公告，公司近日收到股东杨培勇出具的《关于减持公司股份的告知函》，计 划自公告披露之日起15个交易日后的3个月内通过集中竞价方式减持其持有的公司股份不超过25万股， 占公司总股本比例不超过0.14%。 ...

智通财经APP讯，西力科技(688616.SH)发布公告，公司近日收到股东杨培勇出具的《关于减持公司股 份的告知函》，计划自公告披露之日起15个交易日后的3个月内通过集中竞价方式减持其持有的公司股 份不超过25万股，占公司总股本比例不超过0.14%。 ...

每经AI快讯，西力科技（SH 688616，收盘价：12.04元）12月15日晚间发布公告称，公司股东杨培勇先 生系公司特定股东、第三届监事会监事，于2023年10月退休并于2024年4月25日辞去监事职务，持有公 司股份108万股，占公司总股本0.6%，持有的公司股份为公司首次公开发行前取得的股份以及公司资本 公积转增股本所得，已于2024年3月18日解除限售并上市流通。公司近日收到股东杨培勇先生出具的 《关于减持公司股份的告知函》，计划自本公告披露之日起15个交易日后的3个月内通过集中竞价方式 减持其持有的公司股份不超过25万股，占公司总股本比例不超过0.14%。 2024年1至12月份，西力科技的营业收入构成为：仪器仪表占比99.12%，其他业务占比0.88%。 （记者 曾健辉） 每经头条（nbdtoutiao）——"一针两千，童颜针年销3亿元"背后：多家关联方注册地"查无此人"，股民 追问"钱呢"！钱氏姐弟几乎"掏空"江苏吴中，公司即将退市 截至发稿，西力科技市值为22亿元。 ...

格隆汇12月15日丨西力科技(688616.SH)公布，公司近日收到股东杨培勇先生出具的《关于减持公司股 份的告知函》，计划自本公告披露之日起15个交易日后的3个月内通过集中竞价方式减持其持有的公司 股份不超过25万股，占公司总股本比例不超过0.14%。若在减持计划实施期间公司发生送股、资本公积 转增股本等股份变动事项，减持股份数将进行相应调整。 ...

证券代码：688616 证券简称：西力科技 公告编号：2025-038 杭州西力智能科技股份有限公司 股东减持股份计划公告 股东持有的基本情况 公司股东杨培勇先生系公司特定股东、第三届监事会监事，于 2023 年 10 月退休并于 2024 年 4 月 25 日辞去监事职务，持有公司股份 1,080,000 股，占公 司总股本 0.6%，持有的公司股份为公司首次公开发行前取得的股份以及公司资 本公积转增股本所得，已于 2024 年 3 月 18 日解除限售并上市流通。 减持计划的主要内容 公司近日收到股东杨培勇先生出具的《关于减持公司股份的告知函》，计划 自本公告披露之日起 15 个交易日后的 3 个月内通过集中竞价方式减持其持有的 公司股份不超过 250,000 股，占公司总股本比例不超过 0.14%。若在减持计划实 施期间公司发生送股、资本公积转增股本等股份变动事项，减持股份数将进行相 应调整。 | 股东名称 | 杨培勇 | | | | --- | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | □是 | □否 | | | 直接持股 5%以上股东 | □是 | □否 ...

Group 1 - The core point of the article is that Xili Technology reported a total of 5,858 shareholders as of the end of the third quarter [1]

Group 1 - The core viewpoint of the news is that Xili Technology experienced a decline in stock price and trading volume, with significant changes in financing and shareholder metrics [1][2]. - On November 21, Xili Technology's stock fell by 4.87%, with a trading volume of 35.48 million yuan. The net financing buy was -599,200 yuan, indicating a higher level of financing balance compared to the past year [1]. - The financing balance of Xili Technology as of November 21 is 48.54 million yuan, accounting for 2.23% of the circulating market value, which is above the 60th percentile of the past year [1]. Group 2 - As of September 30, the number of shareholders of Xili Technology decreased by 7.37% to 5,858, while the average circulating shares per person increased by 7.95% to 30,621 shares [2]. - For the period from January to September 2025, Xili Technology reported a revenue of 403 million yuan, a year-on-year decrease of 14.19%, and a net profit attributable to the parent company of 66.34 million yuan, down 11.48% year-on-year [2]. - Xili Technology has distributed a total of 196 million yuan in dividends since its A-share listing, with 128 million yuan distributed over the past three years [3].

Core Viewpoint - The company has not exported products to the European Union in the past two years [2] Company Summary - The company responded to investor inquiries on November 14, indicating a lack of exports to the EU region [2]

Group 1 - Company plans to raise no more than 3.6 billion yuan through a private placement to fund seven projects, including a 500,000 kW green power project in Inner Mongolia [1] - Company has received acceptance for a clinical trial application for its self-developed drug for metastatic pancreatic ductal adenocarcinoma [1] - Company intends to establish a joint venture to implement a high-quality gallium arsenide chip construction project with a total investment of 272 million yuan [2] Group 2 - Company reported a revenue of 142 million yuan from pig sales in October, with a total sales volume of 162,800 pigs [3] - Company signed an annual procurement contract to supply 870,000 tons of electrolyte products from 2026 to 2028 [5] - Company plans to reduce its shareholding by up to 3% through various trading methods [7] Group 3 - Company intends to purchase 100 hydrogen fuel cell vehicles for a total price of 78.32 million yuan [9] - Company plans to acquire a 51% stake in a semiconductor equipment company for 510 million yuan [10] - Company has regained eligibility to participate in military procurement activities after being removed from the banned list [12] Group 4 - Company plans to establish a joint venture with state-owned funds for rural development with a total registered capital of 2.87 billion yuan [14] - Company reported a revenue of 1.918 billion yuan from pig sales in October, with a significant year-on-year increase [16][17] - Company plans to distribute a cash dividend of 0.01 yuan per share, totaling 7.9801 million yuan [18] Group 5 - Company has submitted an application for H-share listing on the Hong Kong Stock Exchange [19] - Company received approval for its convertible bond issuance application [20] - Company plans to establish a wholly-owned subsidiary with an investment of 70 million yuan focused on innovative medical research [22] Group 6 - Company reported a 33.87% year-on-year increase in sales volume for October [26] - Company has received a product designation from a leading new energy vehicle brand, with an expected total revenue of approximately 470 million yuan [28] - Company has initiated a key Phase III clinical trial for an innovative eye drop treatment for moderate to severe dry eye syndrome [30] Group 7 - Company reported a total automobile sales volume of 170,700 units in October, a year-on-year decrease of 8.1% [30] - Company plans to invest 16 million USD in establishing a production base in Vietnam [33] - Company has received a warning letter from the regulatory authority due to a breach of commitment by its controlling shareholder [52]